Innovative Technologies 42Bio specializes in advanced magnetic and biomolecule technologies aimed at clinical and veterinary applications, presenting opportunities to offer complementary biotech tools, reagents, or custom solutions that enhance their research and product development efforts.
Market Focus Opportunities With ongoing projects like the magnetic separation device for COVID antibody capture, there is potential to collaborate or supply specialized materials and equipment supporting infectious disease diagnostics and vaccine development.
Growth Potential Operating within a competitive biotech ecosystem and with revenue between one and ten million dollars, 42Bio shows growth ambition, creating avenues for strategic partnerships, funding consultations, or technology licensing to accelerate product commercialization.
Funding & Investment With recent funding of $256,000, there are opportunities for investors or partners to engage in early-stage collaborations, joint ventures, or to provide additional capital aimed at scaling their regenerative medicine solutions.
Digital Presence Maintaining a modern website built on WordPress with active digital tools suggests openness to online collaborations; leveraging digital marketing and outreach strategies can help connect with research institutions and veterinary clinics interested in regenerative solutions.
$50M$100M
$1B$10B
$100M$250M
$50M$100M
$10M$25M42Bio, Inc. uses 8 technology products and services including WordPress, RSS, MySQL, and more. Explore 42Bio, Inc.'s tech stack below.
| 42Bio, Inc. Email Formats | Percentage |
| FLast@42bio.com | 50% |
| FLast@42bio.com | 50% |
Biotechnology ResearchFlorida, United States2-10 Employees
42Bio’s mission is to develop and implement regenerative medicine technologies to advance human and veterinary health. The objective of 42Bio is to apply our magnetic and biomolecule technologies to address unmet needs in clinical and veterinary disease and injury. We aim to advance these technologies to make meaningful and rigorously-studied products that benefit both clinical and scientific communities.
Company Overview
Funding & Financials42Bio, Inc. has raised a total of $256K of funding over 1 rounds. Their latest funding round was raised on Aug 13, 2020 in the amount of $256K.
42Bio, Inc.'s revenue is estimated to be in the range of $1M$10M
Funding & Financials42Bio, Inc. has raised a total of $256K of funding over 1 rounds. Their latest funding round was raised on Aug 13, 2020 in the amount of $256K.
42Bio, Inc.'s revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com